Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
Clinical trial NCT02318602 · COMPLETED
Trial details
- NCT number
- NCT02318602
- Sponsor
- INSYS Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-08
- Primary completion
- 2017-06-22
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.